Abstract
Neurons and neuroendocrine cells store nucleotides in vesicles and release them upon stimulation, leading to intercellular purinergic signaling. The molecular machinery responsible for the vesicular storage of nucleotides was a long standing enigma, however, recently the transporter involving in the process was identified. This article summarizes the history of vesicular storage of nucleotides and the identification of the vesicular nucleotide transporter (VNUT) responsible for the process. The significance of VNUT as a drug target to control purinergic chemical transmission is also discussed.
Keywords: Vesicular nucleotide transporter, secretory granules, synaptic vesicles, ATP, ADP, purinergic chemical transmission, drug target.
Current Pharmaceutical Design
Title:Vesicular Nucleotide Transport: A Brief History and the Vesicular Nucleotide Transporter as a Target for Drug Development
Volume: 20 Issue: 16
Author(s): Miki Hiasa, Natsuko Togawa and Yoshinori Moriyama
Affiliation:
Keywords: Vesicular nucleotide transporter, secretory granules, synaptic vesicles, ATP, ADP, purinergic chemical transmission, drug target.
Abstract: Neurons and neuroendocrine cells store nucleotides in vesicles and release them upon stimulation, leading to intercellular purinergic signaling. The molecular machinery responsible for the vesicular storage of nucleotides was a long standing enigma, however, recently the transporter involving in the process was identified. This article summarizes the history of vesicular storage of nucleotides and the identification of the vesicular nucleotide transporter (VNUT) responsible for the process. The significance of VNUT as a drug target to control purinergic chemical transmission is also discussed.
Export Options
About this article
Cite this article as:
Hiasa Miki, Togawa Natsuko and Moriyama Yoshinori, Vesicular Nucleotide Transport: A Brief History and the Vesicular Nucleotide Transporter as a Target for Drug Development, Current Pharmaceutical Design 2014; 20 (16) . https://dx.doi.org/10.2174/13816128113199990574
DOI https://dx.doi.org/10.2174/13816128113199990574 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Acknowledgment to Contributors
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Benefaction of Herbals in the Management of Urolithiasis
Current Traditional Medicine Current Status of Computer-Aided Drug Design for Type 2 Diabetes
Current Computer-Aided Drug Design Role of the Insulin Receptor Variant Forms in Human Metabolic Disorders
Current Genomics Calcium as a Molecular Target in Angiogenesis
Current Pharmaceutical Design C7-Substituted Estranes and Related Steroids
Mini-Reviews in Organic Chemistry Resistance Exercise Versus Aerobic Exercise Combined with Metformin Therapy in the Treatment of type 2 Diabetes: A 12-Week Comparative Clinical Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Preclinical Study to Evaluate the Effect of Polyherbal Formulation on Metformin: Potential Herb-drug Interaction
The Natural Products Journal Understanding the Molecular and Cellular Changes Behind Aortic Valve Stenosis
Current Pharmaceutical Biotechnology Use of Diverse Chemometric and Validation Methods to Accurately Predict Human Urotensin-II Receptor Antagonist Activity
Current Computer-Aided Drug Design Combinatorial Therapies for Cardiac Regeneration
Recent Patents on Regenerative Medicine Growth of Diabetes Research in United Arab Emirates: Current and Future Perspectives
Current Diabetes Reviews “Epileptic Encephalopathy” of Infancy and Childhood: Electro-Clinical Pictures and Recent Understandings
Current Neuropharmacology NHE-1: A Promising Target for Novel Anti-cancer Therapeutics
Current Pharmaceutical Design Recent Advances on Neural Tube Defects with Special Reference to Valproic Acid
Endocrine, Metabolic & Immune Disorders - Drug Targets RNA Splicing Manipulation: Strategies to Modify Gene Expression for a Variety of Therapeutic Outcomes
Current Gene Therapy Safety and Efficacy of Intra-arterial Tirofiban Injection During Mechanical Thrombectomy for Large Artery Occlusion
Current Neurovascular Research Targeting CD4 to Disrupt Signaling Through Membrane Rafts: Towards a Raft-Based Therapeutics
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Editorial [Hot topic: Adipocytokines in Nonalcoholic Fatty Liver Disease: Key Players Regulating Steatosis, Inflammation and Fibrosis (Executive Editor: Herbert Tilg)]
Current Pharmaceutical Design Systemic Approach to Parenteral Nutrition in the ICU
Current Drug Safety